Audeara Ltd. · ASX:AUA

Audeara — FY2023 Earnings Presentation

8 slides from Audeara's earnings presentation, Aug 31, 2023

  1. Slide 1: FY23 Full Year Financial Results Presentation

    For personal use only FY23 Full Year Financial Results Presentation — 31 August 2023 ASX: AUA Approved for release by the Board of Audeara Limited.

  2. Slide 2: Disclaimer | Important information

    Disclaimer | Important information For personal use only 31 August 2023 This presentation has been prepared by Audeara Limited ACN 604 368 443 (Company) for the sole purpose of providing the Recipient with general information only. This presentation does not purport to be complete, nor does it conta

  3. Slide 3: Performance Highlights | Full-Year ended 30 June 2023

    Performance Highlights | Full-Year ended 30 June 2023 For personal use only $2.9m $3.05m $2.97m $2.62m FY23 Operating In Cash or Equivalents FY23 Revenue FY23 Cash Receipts Cash Outflow at 30 June 2023 well placed to advance 40% YOY 49% YOY 17% YOY international expansion Audeara AUA Technology 30%

  4. Slide 4: Cash Receipts up and Net Cash Usage down

    Cash Receipts up and Net Cash Usage down For personal use only 50% 17%

  5. Slide 5: Sales continue to diversify

    Sales continue to diversify For personal use only $2,905,985 Australian Wholesale $153,845 ▸ Focus on increasing sales per clinic $111,458 $246,307 AUA Technology $2,394,375 ▸ Engineering Services $2,067,410 $61,969 International Wholesale $165,448 ▸ EU - global chains $1,839,993 ▸ US - Independents

  6. Slide 6: Company snapshot

    Company snapshot For personal use only Enterprise value (A$) Top shareholders Share price $0.032 Name Shares Percentage Market cap $4.59M at 30 June 2023 Fortune Pioneer 28,000,000 19.5% Cash As at 30 June 2023 $2.62M Board of Directors 43,515,087 30.0% Debt As at 30 June 2023 $0 Other Top 20 31,302

  7. Slide 7: Board Members

    Board Members For personal use only Dr. James Fielding David Trimboli Dr. Elaine Saunders Bill Peng CEO and Managing Director Non-Executive Chairman Non-Executive Director Executive Director Dr Fielding completed dual Mr Trimboli helped launch Dr Saunders is a Biomedical Mr Peng has extensive experi

  8. Slide 8: Contact

    For personal use only Contact INVESTOR ENQUIRIES Six Degrees Investor Relations Henry Jordan +61 (0) 431 271 538 henry.jordan@sdir.com.au

Audeara — FY2023 Earnings Presentation on 6ix